GlobeNews Wire

Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran

BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed…

4 months ago

AscellaHealth Expands International Operations, Broadens Executive Leadership to Accelerate Global Market Access for Life Sciences

DUBLIN and BERWYN, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the…

4 months ago

BioAro Secures UAE Approval for AI-Enabled Longevity Bioactives, Setting the Stage for Global Expansion

DUBAI, United Arab Emirates and TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioAro Inc., a biotechnology company at the forefront…

4 months ago

Tecan to host Analyst and Media Conference with Capital Markets Update on March 16, 2026

Männedorf, Switzerland, February 10, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) will hold an Analyst and Media Conference…

4 months ago

Hassan Spine & Sports Medicine Rebrands as NefraHealth

New Identity Reflects Patient-First Philosophy, Practice Growth Board-Certified Spine Surgeon Joins Growing Central Jersey Practice OLD BRIDGE, N.J., Feb. 10,…

4 months ago

Age Verification Enters a Stage of Audits, Enforcement, and Penalties

RESTON, Va., Feb. 10, 2026 (GLOBE NEWSWIRE) -- As age checks move from informal self-declared prompts to legally enforceable controls,…

4 months ago

Token Security is a Top 10 Finalist for RSAC 2026 Innovation Sandbox Contest

NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Token Security, the leader in identity-first security for agentic AI, today announced…

4 months ago

Geordie AI Selected as Top 10 Finalist for RSAC 2026 Conference Innovation Sandbox Contest

Geordie AI Selected for Monitoring and Governing AI Agents in Real Time February 10, 2026 08:01 ET  | Source: Geordie…

4 months ago

Ipsen – January 2026 – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article…

4 months ago

AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors

PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS OF MINOR USE IN MAJOR SPECIES DESIGNATION FOR…

4 months ago